Not Signed In -
Mesothelioma |
Malignant Mesothelioma |
Mesothelioma is a form of cancer that is almost always caused by previous exposure to asbestos.[1] In this disease, malignant (cancerous) cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Its most common site is the pleura (outer lining of the lungs and chest cavity), but it may also occur in the peritoneum (the lining of the abdominal cavity) or the pericardium (a sac that surrounds the heart). Most people who develop mesothelioma have wo ...
Wikipedia - [full article]
Mesothelioma Clinical Trials
- PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00053885 - Active, not recruiting
advanced malignant mesothelioma; epithelial mesothelioma; recurrent malignant mesothelioma; sarcomatous mesothelioma
- Sorafenib in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00107432 - Active, not recruiting
advanced malignant mesothelioma; epithelial mesothelioma; recurrent malignant mesothelioma; sarcomatous mesothelioma
- Capecitabine in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00004183 - Active, not recruiting
recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma; sarcomatous mesothelioma; ...
- Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00030459 - Active, not recruiting
localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
- Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00054002 - Active, not recruiting
localized malignant mesothelioma; recurrent malignant mesothelioma; epithelial mesothelioma; sarcomatous mesothelioma
- Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00003723 - Active, not recruiting
advanced malignant mesothelioma; sarcomatous mesothelioma; epithelial mesothelioma
- Pemetrexed Disodium and Gemcitabine in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00060190 - Active, not recruiting
advanced malignant mesothelioma; epithelial mesothelioma; sarcomatous mesothelioma
- Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00075699 - Active, not recruiting
epithelial mesothelioma; localized malignant mesothelioma; advanced malignant mesothelioma
- SU5416 in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00006014 - Active, not recruiting
recurrent malignant mesothelioma; advanced malignant mesothelioma; sarcomatous mesothelioma; epithelial mesothelioma
- ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
ClinicalTrials.gov Identifier: NCT00003034 - Active, not recruiting
localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
- Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed
ClinicalTrials.gov Identifier: NCT00004254 - Active, not recruiting
recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma
- Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
ClinicalTrials.gov Identifier: NCT00004920 - Active, not recruiting
localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
- Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00017186 - Active, not recruiting
localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
- Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
ClinicalTrials.gov Identifier: NCT00006216 - Active, not recruiting
recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma; childhood thorax/respiratory cancer
- Phase II Clinical Study of a Liposomal-Cisplatin Analogue (L-NDDP) Administered Intrapleurally in Patients with Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00004033 - Active, not recruiting
recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma
- Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
ClinicalTrials.gov Identifier: NCT00024271 - Active, not recruiting
localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
- Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
ClinicalTrials.gov Identifier: NCT00137826 - Active, not recruiting
Mesothelioma
- Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00165555 - Active, not recruiting
Pleural Mesothelioma; Malignant Pleural Mesothelioma
- Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
ClinicalTrials.gov Identifier: NCT00003508 - Recruiting
advanced malignant mesothelioma; recurrent malignant mesothelioma
- Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung
ClinicalTrials.gov Identifier: NCT00030745 - Active, not recruiting
localized malignant mesothelioma
- Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00006231 - Active, not recruiting
localized malignant mesothelioma; advanced malignant mesothelioma; perioperative/postoperative complications; Quality of Life
- Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00227630 - Active, not recruiting
Malignant Mesothelioma
- Pleurectomy/Decortication With or Without Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate
ClinicalTrials.gov Identifier: NCT00165503 - Active, not recruiting
Pleural Mesothelioma; Malignant Pleural Mesothelioma
- PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00365053 - Active, not recruiting
Malignant Mesothelioma
- Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate
ClinicalTrials.gov Identifier: NCT00165516 - Active, not recruiting
Pleural Mesothelioma; Malignant Pleural Mesothelioma
- Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00354393 - Active, not recruiting
Malignant Mesothelioma
- Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00003263 - Active, not recruiting
localized malignant mesothelioma
- Pemetrexed Disodium and Either Gemcitabine or Carboplatin in Treating Patients With Advanced Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00101283 - Recruiting
advanced malignant mesothelioma; recurrent malignant mesothelioma
- Trial of Cisplatin, Imatinib Mesylate, and Pemetrexed in Malignant Mesothelioma Patients
ClinicalTrials.gov Identifier: NCT00402766 - Recruiting
Mesothelioma
- Pemetrexed Plus Cisplatin Neoadjuvant Therapy Followed By Surgery and Radiation in Mesothelioma
ClinicalTrials.gov Identifier: NCT00192010 - Recruiting
Mesothelioma
- Dendritic Cell-Based Immunotherapy in Mesothelioma
ClinicalTrials.gov Identifier: NCT00280982 - Recruiting
Malignant Pleural Mesothelioma
- Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00295503 - Recruiting
Mesothelioma
- Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00541073 - Recruiting
Malignant Mesothelioma
- Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00484276 - Recruiting
Mesothelioma
- Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00027703 - Completed
localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma; epithelial mesothelioma; ...
- Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung
ClinicalTrials.gov Identifier: NCT00039182 - Completed
advanced malignant mesothelioma; recurrent malignant mesothelioma; epithelial mesothelioma; sarcomatous mesothelioma
- Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00334594 - Recruiting
Malignant Mesothelioma
- Immunotoxin Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00575770 - Recruiting
Malignant Mesothelioma
- ZD 1839 in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00025207 - Completed
recurrent malignant mesothelioma; advanced malignant mesothelioma; sarcomatous mesothelioma; epithelial mesothelioma
- Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00253409 - Recruiting
Malignant Mesothelioma
- Tomotherapy Treatment for Mesothelioma
ClinicalTrials.gov Identifier: NCT00469196 - Recruiting
Mesothelioma
- Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00072397 - Active, not recruiting
localized malignant mesothelioma
- AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00243074 - Recruiting
Malignant Mesothelioma
- Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00458913 - Recruiting
Malignant Mesothelioma
- AZD2171 in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00309946 - Recruiting
Malignant Mesothelioma
- Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00392444 - Recruiting
Malignant Mesothelioma
- Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00509041 - Recruiting
Malignant Mesothelioma
- Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00459862 - Recruiting
Malignant Mesothelioma
- Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00513877 - Recruiting
Malignant Mesothelioma
- Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00407459 - Not yet recruiting
Mesothelioma
- A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00551252 - Not yet recruiting
Mesothelioma
- Extrapleural Pneumonectomy, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00571298 - Recruiting
Malignant Pleural Mesothelioma
- Cisplatin With or Without LY231514 in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00005636 - Completed
recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma
- Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen
ClinicalTrials.gov Identifier: NCT00316225 - Recruiting
Lung Neoplasms; Non-Small Cell Lung Cancer; Mesothelioma
- Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
ClinicalTrials.gov Identifier: NCT00188890 - Recruiting
Lung Cancer; Mesothelioma
- A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer
ClinicalTrials.gov Identifier: NCT00325494 - Active, not recruiting
Pancreatic Cancer; Mesothelioma; Ovarian Cancer; Non-Small Cell Lung Cancer
- High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
ClinicalTrials.gov Identifier: NCT00002465 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer; Nutrition; stage IV endometrial cancer; Cachexia; advanced malignant mesothelioma; ...
- Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00535951 - Recruiting
Carcinoma, Non-Small-Cell Lung; Mesothelioma
- Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00272558 - Recruiting
Malignant Pleural Mesothelioma
- EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer
ClinicalTrials.gov Identifier: NCT00028782 - Completed
malignant ascites; peritoneal cavity cancer; advanced malignant mesothelioma; localized malignant mesothelioma; recurrent malignant mesothelioma
- ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy
ClinicalTrials.gov Identifier: NCT00061477 - Completed
Mesothelioma
- Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
ClinicalTrials.gov Identifier: NCT00398138 - Recruiting
Leukemia; Lung Cancer; Malignant Mesothelioma; Myelodysplastic Syndromes; Peritoneal Cavity Cancer
- Decitabine and FR901228 in Treating Patients With Advanced Lung Cancer, Esophageal Cancer, Pleural Mesothelioma, or Lung Metastases
ClinicalTrials.gov Identifier: NCT00041158 - Recruiting
Esophageal Cancer; Lung Cancer; Malignant Mesothelioma; Metastatic Cancer
- Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma
ClinicalTrials.gov Identifier: NCT00027508 - Completed
recurrent malignant mesothelioma; advanced malignant mesothelioma
- Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
ClinicalTrials.gov Identifier: NCT00003974 - Active, not recruiting
stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; localized malignant mesothelioma; stage I non-small cell lung cancer
- ALIMTA (pemetrexed) alone or in Combination with Cisplatin for Patients with Malignant Mesothelioma.
ClinicalTrials.gov Identifier: NCT00040625 - Completed
Mesothelioma
- Study of Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, or Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00447447 - Recruiting
Esophageal Cancer; Lung Cancer; Malignant Mesothelioma
- Treatment of Peritoneal Cancer with Surgery, Perfused Heated Cisplatin and Chemotherapy
ClinicalTrials.gov Identifier: NCT00004547 - Recruiting
Abdominal Neoplasm; Colonic Neoplasm; Mesothelioma; Peritoneal Neoplasm
- Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion in Patients with Pulmonary and Pleural Malignancies
ClinicalTrials.gov Identifier: NCT00037817 - Recruiting
Small Cell Carcinoma; Mesothelioma; Non-Small-Cell Lung Carcinoma
- Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00106626 - Recruiting
Neoplasms; Mesothelioma; Non-Small-Cell Lung Carcinoma
- Experimental Drug SS1(dsFv)-PE38 to Treat Cancer
ClinicalTrials.gov Identifier: NCT00006416 - Recruiting
Mesothelioma; Ovarian Neoplasm; Squamous Cell Neoplasm
- Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer
ClinicalTrials.gov Identifier: NCT00024076 - Active, not recruiting
lung metastases; malignant mesothelioma; Non-small cell lung cancer; pulmonary carcinoid tumor; Small Cell Lung Cancer; thymoma and thymic carcinoma
- Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, or Pleura
ClinicalTrials.gov Identifier: NCT00094978 - Recruiting
Carcinoma, Small Cell; Carcinoma, Non-small-cell Lung; Esophageal Neoplasms; Mesothelioma
- Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
ClinicalTrials.gov Identifier: NCT00066404 - Active, not recruiting
Cancer
- Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00386815 - Completed
Malignant Pleural Mesothelioma
- Surgery Plus IPHC to Treat Peritoneal Carcinomatosis
ClinicalTrials.gov Identifier: NCT00454519 - Recruiting
Stomach Neoplasms; Colorectal Neoplasms; Neoplasm Metastasis; Mesothelioma
- A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma
ClinicalTrials.gov Identifier: NCT00190762 - Completed
Mesothelioma
- Gene Therapy for Pleural Malignancies
ClinicalTrials.gov Identifier: NCT00299962 - Recruiting
Pleural Mesothelioma; Metastatic Pleural Effusions
- A Study To Find the Best Dose of SU011248 When Given With Pemetrexed, Pemetrexed and Cisplatin Or Pemetrexed and Carboplatin in Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00528619 - Recruiting
Non-Small Cell Lung Cancer; Mesothelioma; Neoplasms
- Alimta (pemetrexed) plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00087698 - Active, not recruiting
Pleural Neoplasms
- FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer
ClinicalTrials.gov Identifier: NCT00098644 - Recruiting
Esophageal Cancer; Lung Cancer; Malignant Mesothelioma; Metastatic Cancer
- Study of Decitabine in Preventing Tumor Growth
ClinicalTrials.gov Identifier: NCT00001824 - Completed
Esophageal Cancer; Lung Neoplasm; Mesothelioma
- Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
ClinicalTrials.gov Identifier: NCT00019825 - Completed
Esophageal Cancer; Lung Cancer; Malignant Mesothelioma; Metastatic Cancer
- Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
ClinicalTrials.gov Identifier: NCT00372840 - Recruiting
Breast Cancer; Colorectal Cancer; Lung Cancer; Malignant Mesothelioma; Prostate Cancer; Psychosocial Effects/Treatment; Quality of Life; Thymoma and Thymic Carcinoma
- Suberoylanilide Hydroxamic Acid (SAHA)Vs. Placebo in Advanced Malignant Pleural Mesothelioma Refractory to Systemic Chemotherapy.
ClinicalTrials.gov Identifier: NCT00128102 - Recruiting
Advanced malignant pleural mesothelima
- Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs
ClinicalTrials.gov Identifier: NCT00020124 - Completed
Lung Cancer; Malignant Mesothelioma; Metastatic Cancer; Thymoma and Thymic Carcinoma
- Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00251550 - Completed
Malignant Pleural Mesotherioma
- Immunotoxin Therapy in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00006981 - Completed
Cervical Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Malignant Mesothelioma; Ovarian Cancer; Pancreatic Cancer; Peritoneal Cavity Cancer
- Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00066651 - Completed
Cervical Cancer; Fallopian Tube Cancer; Head and Neck Cancer; Lung Cancer; Malignant Mesothelioma; Ovarian Cancer; Pancreatic Cancer; Peritoneal Cavity Cancer
- Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer
ClinicalTrials.gov Identifier: NCT00281125 - Suspended
Non-Small Cell Lung Cancer and Pleural Mesothelioma
- Flavopiridol in Treating Patients With Metastatic or Unresectable Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Mesothelioma, Renal Cell Carcinoma (Kidney Cancer), Squamous Cell Carcinoma of the Head and Neck, Small Cell Lung Cance
ClinicalTrials.gov Identifier: NCT00070239 - Suspended
Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; thorax and respiratory cancer
Resources
- Asbestos Exposure: Questions and Answers
- Cancer Genetics Overview (National Cancer Institute)
email this page
print this page
bookmark this page
feedback on this page
